The meeting organisers Prof John Crown, Prof Mario Sznol and Prof Robert Kerbel welcome you to register for the "13th International Symposium on Translational Research in Oncology".
On the 4th of December 2020, Clinicians and Academics can engage with presentations from world leading oncology researchers, who will deliver the latest advances in oncology treatment.
Meeting provided by Cancer Clinical Research Trust - Charity No.: CHY12210
Start: 4 December 2020
End: 4 December 2020
Cancer Clinical Research Trust (TRANSONC XIII)
Exact Sciences Laboratories
EXACT SciencesExact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.Read more
CHANGING LIVES, TOGETHER
Getting ahead of cancer is crucial no matter where people are in their cancer journey. From earlier cancer detection to treatment guidance and monitoring, we are helping people get the answers they need to make more informed decisions across the cancer continuum.
With a leading portfolio of products for earlier detection and treatment guidance, we help people face the most challenging decisions with confidence.
Our dedication to taking on the impossible fuels everything we do. We are continuously innovating, combining scientific rigor with an open-minded approach to deliver the next big thing.
We are Exact Sciences, and we’re changing lives together through earlier detection and smarter answers.
Daiichi Sankyo Ireland
Daiichi Sankyo IrelandDaiichi Sankyo in IrelandRead more
Daiichi Sankyo is a global pharmaceutical manufacturer based in Japan. With its roots going back to the year 1899, the company has been active in research, development and production of medicines since the early days of the industrialisation of this sector. The goal of Daiichi Sankyo is to satisfy unmet medical needs of patients and healthcare professionals by developing first-in-class and class leading medicines. There are more than 17,000 employees who are working passionately on achieving this goal again and again. Precision is one of the cornerstones of the corporate philosophy to ensure delivery of high-quality products, services and processes. Thus the company aims to fulfil or even exceed the highest quality standards available.
The European origin of Daiichi Sankyo can be traced back to 1910. The company is currently present in all major European pharmaceutical markets.
Daiichi Sankyo Ireland
At Daiichi Sankyo Ireland we pride ourselves on our work with health care professionals in ensuring that the products we bring to market help to address unmet medical needs for a diverse range of patients.
AbbVie Inc.What We DoOur ~30,000 employees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. We come up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions.Read more
We target specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science. We’re constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.
We remember that, as healthcare grows ever more complex, the onus is on us to ensure our medicines are understood by those that use them. We add value and get the best outcomes through the education, services and support we provide beyond our medicines.
MSD IrelandMSD Ireland Human Health is one of Ireland’s leading healthcare companies and our vision is to be the number one, most valued and trusted healthcare company and employer in Ireland.Read more
At MSD Oncology, we’re working to achieve a world where cancer isn’t just treated but cured. Our mission is to deliver breakthrough innovations that extend and improve the lives of people with cancer. We are working to prevent cancer where we can and give patients more ways to treat their cancer, more quality in their lives and more time.
Our extensive Human Health portfolio includes a comprehensive vaccines portfolio for every stage of life as well as innovative solutions and treatments for conditions such as oncology, diabetes, arthritis, allergies, hepatitis C, and HIV. We are also committed to making vaccines that prevent illnesses and conditions and continuing to innovate to develop treatments that treat conditions if they develop.
We believe that the most important thing we make is a difference and we take a patient-centric approach in all that we do. We also challenge ourselves continuously to innovate for the betterment of patients, healthcare providers and the wider healthcare landscape.
MSD Ireland is committed to developing therapies to treat cancer, making a meaningful difference to the lives of patients with this condition and we are playing an important role in this area.
Novartis IrelandRead more
Novartis Global Services Center Dublin
THE CAROLINE FOUNDATION
The Caroline Foundation
THE CAROLINE FOUNDATIONTHE CAROLINE FOUNDATION was established in memory of Caroline Dwyer-Hickey who passed away on 25 March 2013 aged 35 after a nine year battle with cancer. Caroline was a patient of Professor John Crown from the time of her being diagnosed with breast cancer in June 2004. Having benefited from clinical trials in both Ireland and the US Caroline was a public advocate for cancer research, firmly believing that research will one day find a cure – she was a pioneer of cancer research in that she was the first in Ireland to participate on some trials through the CCRT. The Caroline Foundation is built on, and is testimony to that advocacy, that hope and faith in the work of The CCRT.Read more
The mission and purpose of The Caroline Foundation is to raise money to fully fund additional post-doctoral scientific researcher(s) on the Cancer Clinical Research Trust (CCRT) team.
The hope and vision that inspires our endeavour is that through supporting cancer research, those patients who today are participants on the CCRT research programme may benefit from the on-going development of better treatments and at another level that the global cancer research project, of which CCRT is an integral player, will one day not only find a cure but will find a way of preventing cancer.
The committee of The Caroline Foundation has set itself a clear target to raise 1million euro for The Caroline Foundation Cancer Research Fellowship.
The Cancer Clinical Research Trust
The Cancer Clinical Research TrustDespite substantial advances in cancer research, advances which have led to improved treatments and patients outcomes, cancer remains a principal cause of death in Ireland and other countries.Read more
The Cancer Clinical Research Trust is a registered charity which supports a cancer research program which is based throughout many leading institutions in Dublin. The primary focus of our work is “translational research”, that is research which spans the laboratory and the clinic. Prior to the translational era of cancer research, there was a division between medical researchers who investigated new treatments in patients, and cancer scientists, whose work sometimes seemed to have limited relevance to the real world of cancer sufferers.
In the translational approach, all of the new treatments which are tested in patients are derived from solid scientific observations which were made in the laboratory. Similarly, information about the effects of new treatments on the patient and on their cancer is fed back to the laboratory scientists, in order to make the lab research maximally relevant to patient care.
This world-wide clinical-laboratory partnership has resulted in revolutionary new treatments for many types of cancer. Your support of CCRT enables our researchers to participate in and to contribute to the world-wide war on cancer.